Clinical Evaluation of the Mandibular Mini-Implant Overdenture
NCT ID: NCT01064843
Last Updated: 2024-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2010-02-28
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
4 Imtec mini-dental implants (MDI)
4 Imtec MDI
Imtec MDI
4 Imtec MDI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Imtec MDI
4 Imtec MDI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients requesting implant stabilization of existing lower conventional denture.
* Adequate space in anterior mandible for placement of 4 MDI implants.
* Able to maintain adequate oral hygiene and keep dentures clean.
* Healthy enough to have minor surgical procedures.
* Have adequate understanding of written and spoken English or French.
* Capable of providing written informed consent.
Exclusion Criteria
* Has acute or chronic symptoms of parafunctional disorders.
* History of radiotherapy to orofacial region.
* Are or have been taking bisphosphonate IV or other medications (to be evaluated by the researcher).
* Health conditions that may jeopardize treatment (to be evaluated by the researcher).
* Unable or unwilling to return for evaluations or study recalls.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University
OTHER
3M
INDUSTRY
Solventum US LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jocelyne Feine, DDS, MSc, HDR
Role: PRINCIPAL_INVESTIGATOR
Professor, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry, McGill University
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3M ESPE CR-09-020
Identifier Type: -
Identifier Source: org_study_id